The U.S. Food and Drug Administration (FDA) has approved Libtayo® (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell...
Read MoreNovartis announced that the US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for...
Read More
SkinCeuticals unveils Glycolic 10 Renew Overnight – the latest addition to the Correct...
Read MoreSun Pharma has announced late-breaking data from two pivotal Phase-3 clinical trials (reSURFACE 1 and 2) achieving the primary endpoint...
Read MorePRIME previews the 7th International Congress in Aesthetic Dermatology (ICAD 2016), taking place in Bangkok, Thailand, on 24–26 November 2016....
Read MoreAcquisition adds global rights to novel NDSâ„¢ platform topical delivery technology and ANT-1207, investigational botulinum toxin type A product
Read MoreImran Majid and Gousia Sheikh review the use of microneedling for the treatment of acne scars and a growing number of new applications, such as transdermal drug delivery and hair restoration
Read MoreThe number of skin and soft tissue infections (SSTI) has skyrocketed owing to the spread of meticillin-resistant Staphylococcus aureus (MRSA)....
Read More